Clinicopathological characteristics of surgically treated patients with non-B non-C type hepatocellular carcinoma

Kanzo/Acta Hepatologica Japonica

Volumn 51, Issue 12, 2010, Pages 697-705

  Hayashi, Tomoyuki ^a   Hirai, Satoshi ^a   Shimatani, Akiyoshi ^a   Horita, Yosuke ^a   Matsuda, Koichiro ^a   Hiramatsu, Katsushi ^a   Matsuda, Mitsuru ^a   Ogino, Hidero ^a   Shimizu, Kouichi ^a   Uchiyama, Akio ^a   Terahata, Shintaro ^a   Noda, Yatsugi ^a  

^a TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma (HCC); Non B non C; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH)

Indexed keywords

HEPATITIS B CORE ANTIBODY;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE FREE SURVIVAL; HEPATITIS NON B NON C; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PATIENT ASSESSMENT; TREATMENT OUTCOME;

EID: 78651389647     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.51.697     Document Type: Article

References (13)

1. Ohba K, Kubo S, Tamori A, et al. Previous or occult hepatitis B virus infection in hepatitis surface antigen-negative and anti-hapatitis C-negative patients with hepatocellular carcinoma. Surgery Today 2004; 34: 842-848
2. Kusakabe A, Tanaka Y, Orito E, et al. A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan. J Gasrtoenterol 2007; 42: 298-305
3. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468 (Pubitemid 38182303)
4. Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005:54:533-539 (Pubitemid 40403031)